Brevail - Proactive Breast Health
|At Last some good news concerning breast health!||Darrell Miller||02/23/06|
February 23, 2006 03:33 PM
Author: Darrell Miller (email@example.com)
Subject: At Last some good news concerning breast health!
At last, some good news concerning breast health!
Brevail is for women interested in maintaining optimal breast health.
Perhaps you, like many woman, are concerned with the important issue of breast health. Annual mammograms, monthly self breast exams, escalating national statistics, or perhaps an unfortunate occurence in a loved one has raised awareness and concern in many of us.
There is now reason for Optimism
Brevail is the first all-natural product to address the maintenance of orderly cellular division in the preservation of healthy breast tissue.
Research suggests that our bodies use natural plant lignans, now sparse in the modern diet, to sarely and gently buffer and balance potentially adverse effects of excess or toxic estrogens, established as the most well-known cause of certain breast problems.
Estrogen left unchecked may result in rapid multiplication of breast cells, as well as inability for cells to repair potential mutations between cellular divisions.
Body and Nature is balance
Brevail was university researched and developed to increase lignan concentrations in the body to levels found in women who collectively demonstrate an extraordinary history of breast health.
After only 48 hours of Brevail supplementation, women participating in a university based, oral pharmacokinetics study achieved lignan concentrations in plasma and urine equivalent to a reference group of women with a well-established history of extraordinary breast health.
The results is a gentle return to balance between body and nature, just as nature intended.
In addition to the primary purpose of optimal breast health, many women have reported secondary benefits of brevail related to hormonal balance including improvements in pre and peri-menopausal, menopausal and post-menopausal discomforts. Further, many women have reported a greater sense of well-being associated to a reduction of stress and apprehension, and for taking a positive step toward a healthy future.
Brevail has good news for you, a “window” of opportunity.
The good news is a revolutionary new approach to breast health. Though a new approach, managing your “Estrogen window” is time honored, true, and scientifically established.
Your lifetime exposure to estrogen is the most well-known risk factor for breast related health challenges. Your cumulative lifetime exposure to estrogens is referred to as your “Estrogen window.” Influences that increase and extend exposure to estrogen are said to “open” the window. Those that reduce or shorten exposure are said to “Close “ it. The wider and longer the window is left open, the greater your risk for breast related complications.
Managing your estrogen window empowers you to choose a healthy future.
Brevail is the first all-natural product designed to address the estrogen window by gently displacing excess or toxic estrogens. Adequate rest, exercise, a plant-based diet, and avoidance of alcohol are also ways to which you can consciously choose to manage your estrogen window toward a healthy future.
Make a decision for health, life, and vitality!
Proactive Breast Health is a monumental shift in thinking and action, away for passive resignation and toward proactive empowerment. The difference between fate and destiny is that you can plan your destiny in advance. Make a commintment to Brevail, and make a commitment to health, life, and vitality today.
Brevail donates a percentage of all proceeds to the Breast Cancer Prevention Foundation, established to fund scientific and clinical research into breast cancer prevention, as well as to educate the public and medical community on proactive and preventative breast health measures, and for the purpose of outreach and support for women with breast cancer.
Brevail, winner of two consecutive research grants
Brevail was awarded an unprecedented two consecutive research grants from the Washington Technology Center, University of Washington, in the course of the 6-year span in which it was developed. Lignan Based strategies for Cancer Prevention was the topic and title of the grants.